Skip to content
10-Q

Quarterly Report

JINZANGHUANG TIBET PHARMACEUTICALS, INC.

0001096906-12-001490

← back to feed
Filed
May 17, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · May 17, 2012 40.67M sh
Stockholders Equity Q3 2012 · Mar 31, 2012 $7.59M
Stockholders Equity Q3 2012 · Jun 30, 2011 $3.05M
Total Liabilities Q3 2012 · Mar 31, 2012 $661.95K
Total Liabilities Q3 2012 · Jun 30, 2011 $562.42K
Current Assets Q3 2012 · Mar 31, 2012 $8.05M
Current Assets Q3 2012 · Jun 30, 2011 $3.18M
Total Assets Q3 2012 · Mar 31, 2012 $8.65M
Total Assets Q3 2012 · Jun 30, 2011 $3.77M
Capex Q3 2012 · Mar 31, 2011 $3.36K
Operating Cash Flow Q3 2012 · Mar 31, 2011 $977.61K
Sga Expense Q3 2012 · Mar 31, 2011 $113.49K
Sga Expense Q3 2012 · Mar 31, 2011 $212.23K
Net Income Q3 2012 · Mar 31, 2011 $819.17K
Net Income Q3 2012 · Mar 31, 2011 $1.09M
Operating Income Q3 2012 · Mar 31, 2011 $1.15M
Operating Income Q3 2012 · Mar 31, 2011 $1.54M
Gross Profit Q3 2012 · Mar 31, 2011 $1.27M
Gross Profit Q3 2012 · Mar 31, 2011 $1.75M
Cost Of Revenue Q3 2012 · Mar 31, 2011 $63.44K
Cost Of Revenue Q3 2012 · Mar 31, 2011 $156.61K